Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEPHRON: Nifedipine and Enalapril vs Nifedipine and Labetalol for Postpartum Hypertension
NCT07363343Recruiting
- Sponsor
- Cleveland Clinic
- Start
- Mar 2026
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of enalapril in hypertension (HTN) and preeclampsia (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Composite postpartum hypertension treatment failure at 6 weeks. Started Mar 2026; status: recruiting.
02
Drugs
enalapril
03
Conditions
hypertension (HTN)preeclampsia
Beyond the preview
Go deeper on NCT07363343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07363343.